Neuroendocrine Cancer: Radiotherapy

(asked on 24th March 2025) - View Source

Question to the Department of Health and Social Care:

To ask His Majesty's Government what plans they have to increase funding for minimally invasive cancer therapies, in particular selective internal radiation therapy for neuroendocrine tumours that have spread to the liver.


Answered by
Baroness Merron Portrait
Baroness Merron
Parliamentary Under-Secretary (Department of Health and Social Care)
This question was answered on 2nd April 2025

Radiotherapy treatment for cancer is highly individualised and decisions about cancer treatment are typically made by clinicians and multidisciplinary teams of healthcare professionals. They consider all aspects of a patient's health and circumstances when recommending treatment options. While certain treatments may not be advised for some patients, these decisions are based on medical assessments and what is best for the individual's overall health and well-being.

The National Cancer Plan, coming later this year, will set out how we will seek to improve the experience and outcomes for people at every stage of the cancer pathway. It will look at how we can improve communication and coordination for patients, so that they feel informed, empowered, and in control of their care.

Reticulating Splines